Interleukin 1 production by human monocytes induced in culture with K562 cells

A Szkaradkiewicz1

  • 1Institute of Microbiology and Infectious Diseases, Academy of Medicine, Poznań, Poland.

Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
|January 1, 1991
PubMed

Insights

Neoplastic cells stimulate interleukin 1 (IL-1) production in human monocytes, though less effectively than bacterial lipopolysaccharide or iron particles. This immune response was also observed with allogeneic leukocytes.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Monocytes are key immune cells involved in regulating inflammatory responses.
  • Interleukin 1 (IL-1) is a critical cytokine produced by monocytes that modulates immune cell activity.
  • The interaction between neoplastic cells and immune cells can influence cytokine production and immune surveillance.

Purpose of the Study:

  • To investigate the effect of K562 neoplastic cells on interleukin 1 (IL-1) production by human peripheral blood monocytes.
  • To compare the IL-1 inductive capacity of neoplastic cells with known stimulants like bacterial lipopolysaccharide (LPS) and iron particles.
  • To assess the ability of non-malignant allogeneic leukocytes (PBL) to induce IL-1 production from monocytes.

Main Methods:

  • Monocyte cultures from healthy humans were stimulated with K562 neoplastic cells, LPS, or iron particles.
  • Co-culture experiments were performed using monocytes and allogeneic peripheral blood leukocytes (PBL).
  • Interleukin 1 (IL-1) production was quantified using a concanavalin A (Con A) thymocyte co-activation assay with colorimetric proliferation measurement.

Main Results:

  • Monocytes secreted IL-1 upon stimulation with K562 neoplastic cells and in co-cultures with allogeneic PBL.
  • Bacterial lipopolysaccharide (LPS) and iron particles were more potent stimulators of IL-1 production compared to neoplastic cells.
  • Dexamethasone treatment abolished IL-1 activity, while soluble immune response suppressor (SIRS) did not inhibit IL-1 activity.

Conclusions:

  • Neoplastic cells can induce IL-1 secretion from human monocytes, indicating a potential role in modulating the immune microenvironment.
  • The IL-1 inductive capacity of neoplastic cells is less pronounced than that of potent immune activators like LPS.
  • Monocyte-derived IL-1 activity is sensitive to dexamethasone but not to soluble immune response suppressor (SIRS).